Haematology

The role of the Haematology Department

Hematology is the medical specialty that deals with diseases of the blood and immune system. Our department offers comprehensive, specialized care for patients suffering from these diseases.

Haematology consultation

Our mission is to provide specialized, personalized care for every patient. If you don't yet have a precise diagnosis, you can book an appointment in general hematology, and you will then be referred to one of our experts.

Our specialties

In addition to general hematology consultations, our department is organized into several clinics and centers of expertise:

  • Thrombosis and haemostasis clinic: management of coagulation disorders and bleeding disorders.
  • Red blood cell and iron disorders clinic: specializing in the management of anemia and iron disorders.
  • Reference center for hereditary red blood cell diseases: sickle cell anemia, thalassemia and other rare red blood cell diseases.
  • Reference center for porphyrias: Diagnosis and treatment of porphyrias.
  • Castelman disease reference center: Management of this rare disease.
  • Reference center for the management of Thrombocytopenic Purpura.
  • Histiocytosis reference center: Care for patients with these rare diseases.
  • Haematological oncological diseases are treated at the Institut Jules Bordet, a center of excellence for cancer care.
     

Our General Hematology care units at Erasme Hospital

  • An inpatient unit: for patients requiring continuous monitoring and specific care for rare blood disorders (sickle cell disease, thalassemia, porphyria, thrombotic thrombocytopenic purpura).
  • An outpatient treatment unit: for patients requiring treatment without prolonged hospitalization. 
     

Our Hemato-Oncology care units at the Institut Jules Bordet

  • Two in-patient units: for tailored care of patients with blood cancers.
  • An outpatient treatment unit: for treatments requiring monitoring without prolonged hospitalization.
  • Cytapheresis unit: for treatments involving the separation and collection of blood cells.
  • A cell therapy unit: for innovative therapies such as CAR-T cells and gene therapies.

Genetic counselling - hereditary red blood cell disorders

Genetic counseling is dedicated to rare hereditary red blood cell diseases (sickle cell anemia, thalassemia, spherocytosis, elliptocytosis, pyruvate kinase deficiency, etc.). The consultation is designed to inform a person or family who is or may be at risk of one of these diseases, to help them understand the disease, the tests required for diagnosis and the interpretation of test results. In this way, a person or family has the opportunity to make an informed choice about the health of their loved ones in relation to a rare hereditary red blood cell disease.

For more information, please make an Cons [dot] Hemato [at] hubruxelles [dot] be (appointment with Prof. Béatrice Gulbis)' specialist consultation.

Our team

The Haematology Department is managed by Prof. Virginie De Wilde, Department Head, and Prof. Nathalie Meuleman, Associate Department Head of the Hematology Department at Institut Jules Bordet.

Our team is made up of renowned hematology specialists, supported by nursing and administrative staff dedicated to providing the best possible care for our patients.

Image
Cheffes du Service d'Hématologie de l'H.U.B

Our specialists

Focus

Research in Hematology

Thanks to our research units, our commitment to scientific excellence and therapeutic innovation translates into rapid access to new medicines.

Clinical research

We work with international partners to access unique resources and participate in large-scale clinical trials. More info.

Basic Research

Our basic research laboratory focuses on the underlying mechanisms of hematological diseases. By better understanding these mechanisms, we can develop more effective and targeted therapies. More info

Translational research

The laboratory at LHUB (Laboratoire Hospitalier Universitaire de Bruxelles) plays a crucial role in the transition from fundamental discoveries to practical clinical applications. This process, known as translational research, ensures that our scientific discoveries directly benefit patients.